9170 Safety and efficacy of first-line bevacizumab (Bv) plus chemotherapy in elderly patients (pts) with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): SAiL (MO19390)

Pilar Garrido, N. Thatcher, L. Crinò, Éric Dansin, Janessa Laskin, Nick Pavlakis, C.M. Tsai, Martin Reck, C. Schneider, Frank Griesinger

European Journal of Cancer Supplements · 2009 · 11 citations · 0 references

Concepts